Lars Harbaum

2.0k total citations
52 papers, 930 citations indexed

About

Lars Harbaum is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Lars Harbaum has authored 52 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Oncology. Recurrent topics in Lars Harbaum's work include Pulmonary Hypertension Research and Treatments (26 papers), Cardiovascular Function and Risk Factors (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Lars Harbaum is often cited by papers focused on Pulmonary Hypertension Research and Treatments (26 papers), Cardiovascular Function and Risk Factors (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Lars Harbaum collaborates with scholars based in Germany, Austria and United Kingdom. Lars Harbaum's co-authors include Cord Langner, Peter Kornprat, Richard A. Lindtner, Marion J. Pollheimer, Andrea Schlemmer, Peter Rehak, Jan K. Hennigs, Johannes Betge, Hans Klose and Nicole Lüneburg and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Lars Harbaum

49 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Harbaum Germany 18 388 321 201 188 126 52 930
Shinobu Kunugi Japan 14 312 0.8× 188 0.6× 186 0.9× 176 0.9× 41 0.3× 74 774
Xiaoxiao Guo China 18 409 1.1× 184 0.6× 139 0.7× 101 0.5× 206 1.6× 93 917
Yasuji Yoshikawa Japan 17 260 0.7× 330 1.0× 522 2.6× 171 0.9× 78 0.6× 51 1.1k
Xiangqian Su China 18 594 1.5× 395 1.2× 380 1.9× 324 1.7× 48 0.4× 103 1.3k
Manuela Motta Italy 17 198 0.5× 370 1.2× 207 1.0× 440 2.3× 74 0.6× 26 1.3k
Bang-li Hu China 17 171 0.4× 252 0.8× 262 1.3× 173 0.9× 59 0.5× 63 866
Yukiko Niwa Japan 20 380 1.0× 402 1.3× 223 1.1× 405 2.2× 52 0.4× 41 913
Nobuyuki Hiruta Japan 17 231 0.6× 153 0.5× 137 0.7× 328 1.7× 148 1.2× 88 875
Tsukasa Hotta Japan 18 252 0.6× 544 1.7× 226 1.1× 438 2.3× 67 0.5× 85 1.0k
John Hyngstrom United States 19 181 0.5× 811 2.5× 332 1.7× 286 1.5× 115 0.9× 68 1.3k

Countries citing papers authored by Lars Harbaum

Since Specialization
Citations

This map shows the geographic impact of Lars Harbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Harbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Harbaum more than expected).

Fields of papers citing papers by Lars Harbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Harbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Harbaum. The network helps show where Lars Harbaum may publish in the future.

Co-authorship network of co-authors of Lars Harbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Harbaum. A scholar is included among the top collaborators of Lars Harbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Harbaum. Lars Harbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klose, Hans, et al.. (2024). Right ventricular strain to systolic pulmonary artery pressure ratio in response to treatment of pulmonary arterial hypertension. ERJ Open Research. 10(4). 985–2023. 1 indexed citations
3.
Hennigs, Jan K., et al.. (2023). Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension. ERJ Open Research. 9(3). 72–2023. 2 indexed citations
4.
Hennigs, Jan K., Tim Oqueka, Marcel Simon, et al.. (2022). Respiratory muscle dysfunction in long-COVID patients. Infection. 50(5). 1391–1397. 30 indexed citations
5.
Wilkins, Martin R., Mikel A. McKie, Martin Law, et al.. (2021). Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single‐arm efficacy. Pulmonary Circulation. 11(4). 1–12. 18 indexed citations
6.
Harbaum, Lars, et al.. (2020). The application of ‘omics’ to pulmonary arterial hypertension. British Journal of Pharmacology. 178(1). 108–120. 22 indexed citations
7.
Ulrich, Anna, John Wharton, Emilia M. Swietlik, et al.. (2019). Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension. European Respiratory Journal. 55(2). 1901486–1901486. 29 indexed citations
8.
Olschewski, Andrea, Eva Berghausen, Christina A. Eichstaedt, et al.. (2018). Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 4–10. 26 indexed citations
9.
Harbaum, Lars, Pavandeep Ghataorhe, John Wharton, et al.. (2018). Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension. Thorax. 74(4). 380–389. 30 indexed citations
10.
Ghataorhe, Pavandeep, et al.. (2017). Pulmonary arterial hypertension – progress in understanding the disease and prioritizing strategies for drug development. Journal of Internal Medicine. 282(2). 129–141. 21 indexed citations
11.
Harbaum, Lars, Marcel Simon, Tim Oqueka, et al.. (2017). Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension. BMC Pulmonary Medicine. 17(1). 72–72. 32 indexed citations
12.
Betge, Johannes, Nora Schneider, Lars Harbaum, et al.. (2016). MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 469(3). 255–265. 102 indexed citations
13.
Max, Nicole, Lars Harbaum, Marion J. Pollheimer, et al.. (2016). Tumour budding with and without admixed inflammation: two different sides of the same coin?. British Journal of Cancer. 114(4). 368–371. 16 indexed citations
14.
Harbaum, Lars, Sara Yousef, Nicole Lüneburg, et al.. (2016). Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension. BMC Pulmonary Medicine. 16(1). 145–145. 17 indexed citations
15.
Wellbrock, Jasmin, Lars Harbaum, Hauke Stamm, et al.. (2015). Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension. Lung. 193(4). 567–570. 16 indexed citations
16.
Harbaum, Lars, Jan K. Hennigs, Nicole Lüneburg, et al.. (2014). N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency. PLoS ONE. 9(4). e94263–e94263. 12 indexed citations
17.
Harbaum, Lars, Jasmin Wellbrock, Jan K. Hennigs, et al.. (2014). M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines. European Respiratory Journal. 44(Suppl 58). P311–P311.
18.
Harbaum, Lars, Marion J. Pollheimer, Peter Kornprat, et al.. (2014). Peritumoral eosinophils predict recurrence in colorectal cancer. Modern Pathology. 28(3). 403–413. 56 indexed citations
19.
Harbaum, Lars, Andreas H. Marx, Eray Goekkurt, Philippe Schafhausen, & Djordje Atanackovic. (2013). Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity. International Journal of Hematology. 99(1). 91–94. 10 indexed citations
20.
Harbaum, Lars, Marion J. Pollheimer, Peter Kornprat, et al.. (2011). Keratin 7 expression in colorectal cancer – freak of nature or significant finding?. Histopathology. 59(2). 225–234. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinobu Kunugi Breakdown of academic impact, for papers by Xiaoxiao Guo Breakdown of academic impact, for papers by Yasuji Yoshikawa Breakdown of academic impact, for papers by Xiangqian Su Breakdown of academic impact, for papers by Manuela Motta Breakdown of academic impact, for papers by Bang-li Hu Breakdown of academic impact, for papers by Yukiko Niwa Breakdown of academic impact, for papers by Nobuyuki Hiruta Breakdown of academic impact, for papers by Tsukasa Hotta Breakdown of academic impact, for papers by John Hyngstrom
Rankless by CCL
2026